239 related articles for article (PubMed ID: 23325866)
1. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2013 Jan; 346():f114. PubMed ID: 23325866
[TBL] [Abstract][Full Text] [Related]
2. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V
BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
Wright E; Schofield PT; Seed P; Molokhia M
PLoS One; 2012; 7(10):e47616. PubMed ID: 23112825
[TBL] [Abstract][Full Text] [Related]
4. Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case-control studies using two primary-care databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
Br J Cancer; 2013 Aug; 109(3):795-806. PubMed ID: 23868009
[TBL] [Abstract][Full Text] [Related]
5. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea.
Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW
PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
7. Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case-control studies.
Houston MG; McMenamin Ú; Johnston B; McDowell RD; Hughes CM; Murchie P; Cardwell CR
Br J Clin Pharmacol; 2023 Sep; 89(9):2757-2766. PubMed ID: 37117154
[TBL] [Abstract][Full Text] [Related]
8. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
[TBL] [Abstract][Full Text] [Related]
9. Exposure to oral bisphosphonates and risk of esophageal cancer.
Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
[TBL] [Abstract][Full Text] [Related]
10. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers.
Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC
PLoS One; 2015; 10(10):e0140180. PubMed ID: 26445463
[TBL] [Abstract][Full Text] [Related]
11. The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
Busby J; Murchie P; Murray L; Iversen L; Lee AJ; Spence A; Watson MC; Cardwell CR
Int J Cancer; 2017 Apr; 140(8):1828-1835. PubMed ID: 28120338
[TBL] [Abstract][Full Text] [Related]
12. Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ Open; 2012; 2(1):e000548. PubMed ID: 22240651
[TBL] [Abstract][Full Text] [Related]
13. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
[TBL] [Abstract][Full Text] [Related]
14. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M;
Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594
[TBL] [Abstract][Full Text] [Related]
15. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
16. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases.
Vinogradova Y; Dening T; Hippisley-Cox J; Taylor L; Moore M; Coupland C
BMJ; 2021 Sep; 374():n2182. PubMed ID: 34588168
[TBL] [Abstract][Full Text] [Related]
17. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L
Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063
[TBL] [Abstract][Full Text] [Related]
18. Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
Choi D; Choi S; Chang J; Park SM
Osteoporos Int; 2020 Apr; 31(4):775-782. PubMed ID: 32034451
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.
Wright E; Schofield PT; Molokhia M
BMJ Open; 2015 Dec; 5(12):e007133. PubMed ID: 26644118
[TBL] [Abstract][Full Text] [Related]
20. Saving bones without risking brain-bisphosphonates and risk of stroke: matched case-control study.
Asghar ZB; Godoy Caballero A; Pathirannehelage S; Williams J; McKay S; Grassby P; de Lusignan S; Niroshan Siriwardena A
Osteoporos Int; 2019 Sep; 30(9):1845-1854. PubMed ID: 31214750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
